Dr. John Campbell - Increased cancers after mRNA vaccines

Dr. John Campbell
Sep 6, 2025
Increased cancers after mRNA vaccines
https://www.youtube.com/watch?v=3dnIGqUlluc
COVID-19 vaccination, all-cause mortality, and hospitalization for cancer: 30-month cohort study in an Italian province

https://pubmed.ncbi.nlm.nih.gov/40881...

https://pmc.ncbi.nlm.nih.gov/articles...

https://www.thefocalpoints.com/p/brea...

The rate of first hospitalization for cancer of any site

Unvaccinated group: 0.85%

Vaccinated group (one or more doses): 1.15%

N = 296,015 population

Hospital admission with a cancer diagnosis, 3,124

(p less than 0.001).

Vaccination with at least one dose

Colon-rectal cancer HR: 1.34

Breast cancer HR: 1.54

Bladder cancer HR: 1.62

After three or more vaccine doses

Breast cancer HR: 1.36

Bladder cancer HR: 1.43

All significant

After one dose (180 days after)

Rate of first hospital admissions for cancers

All cancers: up 23% significant

Colorectal: up 34% significant

Lung: down = 10%

Breast: up 54% significant

Uterine: up = 75%

Ovarian: up = 65%

Prostate: up = 1%

Bladder: up 62% significant

Thyroid: up =58%

Haematological: up = 33%

After three dose (180 days after administration of third dose)

All cancers: up = 9%

Colorectal: up = 14%

Lung: down = 5%

Breast: up=36% significant

Uterine: up = 20%

Ovarian: up = 86%

Prostate: down = 3%

Bladder: up=43% significant

Thyroid: down = 3%

Haematological: up = 5%

More about the study

Population-wide cohort analysis

Evaluating the risk of all-cause death and cancer hospitalization by SARS-CoV-2 immunization status.

National Health System official data, entire population, Pescara province, Italy

Followed from June 2021 (six months after the first vaccination) to December 2023.

296,015 residents aged ≥11 years

Hospital admission with a cancer diagnosis, 3,124

16.6% were unvaccinated

83.3% received ≥1 dose

62.2% ≥3 doses.

Compared with the unvaccinated, those receiving ≥1 dose showed a significantly lower likelihood of all-cause death

Cancer hospitalization was significant only among the subjects with no previous SARS-CoV-2 infection

Some cancer risks went down after 1 year (relative to 180 days)

(But breast, ovarian and bladder went up at one year relative to 180 days after 1 vaccine dose)

Given that it was not possible to quantify the potential impact of the healthy vaccinee bias and unmeasured confounders, these findings are inevitably preliminary.
How this content was made
Auto-dubbed
Audio tracks for some languages were automatically generated. Learn more